Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 37, 2011, Pages 15074-15078

  Lecomte, Nicolas ^a   Njardarson, Jon T ^a   Nagorny, Pavel ^a   Yang, Guangli ^a   Downey, Robert ^a   Ouerfelli, Ouathek ^a   Moore, Malcolm A S ^a   Danishefsky, Samuel J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; CARBOXYMETHYL MIGRASTATIN ETHER; ETHER DERIVATIVE; MIGRASTATIN DERIVATIVE; MIGRASTATIN ETHER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG SMALL CELL CANCER; MALE; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; ETHERS; HUMANS; LUNG NEOPLASMS; MACROLIDES; MALE; MICE; NEOPLASM METASTASIS; PIPERIDONES; SMALL CELL LUNG CARCINOMA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

STREPTOMYCES;

EID: 80053084120     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015247108     Document Type: Article

References (15)

1. Nakae K, et al. (2000) Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F. J Antibiot 53:1130-1136.
2. Nakae K, et al. (2000) Migrastatin, a novel 14-membered lactone from Streptomyces sp. MK929-43F. J Antibiot 53:1228-1230.
3. Takemoto Y, et al. (2001) Migrastatin, a novel 14-membered ring macrolide, inhibits anchorage-independent growth of human small cell lung carcinoma Ms-1 cells. J Antibiot 54:1104-1107. (Pubitemid 34110882)
4. Nakamura H, et al. (2002) Absolute configuration of migrastatin, a novel 14-membered ring macrolide. J Antibiot 55:442-444.
5. Danishefsky SJ (1986) Reflections on organic synthesis: The evolution of a general strategy for the stereoselective construction of polyoxygenated natural products. Aldrichimica Acta 19:59-69.
6. Gaul C, Njardarson JT, Danishefsky SJ (2003) The total synthesis of (+)-migrastatin. J Am Chem Soc 125:6042-6043. (Pubitemid 36582961)
7. Njardarson JT, Gaul C, Shan D, Huang XY, Danishefsky SJ (2004) Discovery of potent cell migration inhibitors through total synthesis: Lessons from structure-activity studies of (+)-migrastatin. J Am Chem Soc 126:1038-1040. (Pubitemid 38140731)
8. Ju J, Lim SK, Jiang H, Seo JW, Shen B (2005) Iso-migrastatin congeners from Streptomyces platensis and generation of a glutarimide polyketide library featuring the dorrigocin, lactimidomycin, migrastatin, and NK30424 scaffolds. J Am Chem Soc 127:11930-11931. (Pubitemid 41233704)
9. Oskarsson T, et al. (2010) Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: In vivo and mechanistic studies on the migrastatin core ether analog. J Am Chem Soc 132:3224-3228.
10. Shan D, et al. (2005) Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci USA 102:3772-3776. (Pubitemid 40354687)
11. Minn AJ, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524. (Pubitemid 41112921)
12. Chen L, Yang S, Jakoncic J, Zhang JJ, Huang XY (2010) Migrastatin analogues target fascin to block tumor metastasis. Nature 464:1062-1066.
13. Nagorny P, et al. (2010) Confirmation of the structures of synthetic derivatives of migrastatin in the light of recently disclosed crystallographically based claims. Tetrahedron Lett 51:3873-3875.
14. Rodina A, et al. (2007) Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nat Chem Biol 3:498-507. (Pubitemid 47080368)
15. Carpenter AE, et al. (2006) CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. GenomeBiology 7:R100.